Evidence map›Paper›PMID 41937537›Full record

ArticleBMB reports2026

Cereblon enhances hepatic hepcidin production through estrogen-related receptor gamma activation.

Seungwon An, Chung Hyo Kang, Taehyun Park, Balachandar Nedumaran, Younjoo Sung, Taehoon Chung, Chul-Seung Park, Ali R Djalilian, Yong Deuk Kim

Abstract read
In one paragraph

Article in BMB reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Seungwon AnDepartment of Ophthalmology and Visual Sciences, University of Illinois at Chicago, Chicago, Illinois 60612, 4Clinical Stem Cell laboratory, UI Blood & Marrow Transplant Program, University of Illinois Hospital and Health Sciences System, Chicago, Illinois 60612, Korea.
Chung Hyo KangDUKSAN Institute of Biomedical and Life Science, Gwangmyeong 14348; Young Sciences, Inc., Seoul 07797, Korea.
Taehyun ParkDUKSAN Institute of Biomedical and Life Science, Gwangmyeong 14348; Young Sciences, Inc., Seoul 07797, Korea.
Balachandar NedumaranBarbara Davis Center for Diabetes, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado 80045, USA.
Younjoo SungDUKSAN Institute of Biomedical and Life Science, Gwangmyeong 14348; Young Sciences, Inc., Seoul 07797, Korea.
Taehoon ChungDUKSAN Institute of Biomedical and Life Science, Gwangmyeong 14348; Young Sciences, Inc., Seoul 07797, Korea.
Chul-Seung ParkSchool of Life Sciences and Cell Logistics Research Center, Gwangju Institute Science and Technology, Gwangju 61005, Korea.
Ali R DjalilianDepartment of Ophthalmology and Visual Sciences, University of Illinois at Chicago, Chicago, Illinois 60612, USA.
Yong Deuk KimDUKSAN Institute of Biomedical and Life Science, Gwangmyeong 14348; Young Sciences, Inc., Seoul 07797, Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hepcidin (encoded by the HAMP gene), produced primarily by hepatocytes, is the master regulator of systemic iron homeostasis. Its dysregulation contributes to various iron-related metabolic disorders. Cereblon (CRBN) has been implicated in metabolic regulation, while estrogen-related receptor gamma (ESRRG) is known to govern energy homeostasis and mitochondrial function. In this study, we demonstrate a novel CRBN-ESRRG signaling pathway that mediates endoplasmic reticulum (ER) stress-induced hepatic HAMP expression. In mice and primary hepatocytes exposed to tunicamycininduced ER stress, gene expression and biochemical analyses revealed significant increases in the transcript levels of hepatic Crbn, Esrrg, and Hamp. Correspondingly, hepcidin protein levels were elevated, accompanied by reduced serum iron levels and increased cellular iron levels, consistent with hepcidinmediated regulation of iron distribution. Overexpression of Crbn enhanced ESRRG expression and increased hepatic hepcidin production, while knockdown of either Crbn or Esrrg attenuated this response. Chromatin immunoprecipitation assays demonstrated enhanced recruitment of ESRRG to the Hamp promoter. Collectively, these findings identify a CRBN-ESRRG regulatory axis that drives hepatic HAMP expression under ER stress and suggest a potential therapeutic target for ER stress-associated metabolic and iron disorders. [BMB Reports 2026; 59(5): 291-298].

Indexed as

Adaptor Proteins, Signal TransducingHepcidinsLiverReceptors, EstrogenUbiquitin-Protein LigasesAnimalsEndoplasmic Reticulum StressHepatocytesHumansIronMiceMice, Inbred C57BLSignal TransductionAdaptor Proteins, Signal TransducingCrbn protein, mouseEsrrg protein, mouseHepcidinsIronReceptors, EstrogenUbiquitin-Protein Ligases

Identifiers

PMID41937537
PMCPMC13220105

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.